Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia
Clinical trial NCT01059786 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01059786
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2022-12-15
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.